{
  "ptid_time": "019_S_4252_2011-09-28",
  "img_path": "/data/qiuhui/data/adni/images/019_S_4252/2011-09-28/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 61,708 mm³, 66.9% above the reference mean. With a Z-score of 1.81 (96.5th percentile), this represents moderate enlargement; hippocampal volume measures 4,800 mm³, 26.1% below the reference mean. With a Z-score of -2.09 (1.8th percentile), this represents significant atrophy; whole brain volume measures 894,110 mm³, 3.7% below the reference mean. With a Z-score of -0.44 (33.0th percentile), this represents normal volume ; entorhinal cortex volume measures 2,468 mm³, 28.7% below the reference mean. With a Z-score of -1.55 (6.0th percentile), this represents moderate atrophy; fusiform gyrus volume measures 13,754 mm³, 14.6% below the reference mean. With a Z-score of -1.10 (13.6th percentile), this represents mild atrophy; middle temporal gyrus volume measures 17,587 mm³, 2.5% below the reference mean. With a Z-score of -0.22 (41.4th percentile), this represents normal volume . ",
  "text_data": "Age is 86.5 years. Gender is Female. Education: 16 years. Handedness: Right. Race: White. Medical history: Neurologic; Cardiovascular; Dermatologic-Connective Tissue; Musculoskeletal; Endocrine-Metabolic; Renal-Genitourinary; Allergies or Drug Sensitivities; Major Surgical Procedures. MMSE: 22.0. MoCA: 16.0. Logical Memory: 5.0. Laboratory findings: Basophils: 0.09 (significant elevated). APOEε4 alleles: 1.0. Biomarker levels: Florbetapir (AV45): 1.47 SUVR (profound elevated); Amyloid beta: 556.40 pg/mL (mild reduced); Total tau: 303.70 pg/mL (normal ); Phosphorylated tau: 32.08 pg/mL (mild elevated). ",
  "true_diagnosis": "Diagnosis: AD.",
  "gpt_diagnosis": "Reasoning: The patient shows significant hippocampal atrophy (Z-score -2.09) and moderate entorhinal cortex atrophy (Z-score -1.55), both key regions in Alzheimer's pathology. Combined with elevated AV45 (amyloid PET) and mild Aβ reduction, this strongly suggests Alzheimer's neurodegeneration. Cognitive scores (MMSE 22, MoCA 16) indicate impairment but not severe dementia.  \n\nDiagnosis: **Mild Cognitive Impairment (MCI) due to Alzheimer's disease**  \nConfidence: **High**  \n\n(Note: While cognitive scores are borderline for dementia, the structural and biomarker profile aligns more closely with MCI in the Alzheimer's continuum. The profound AV45 elevation and hippocampal atrophy are highly indicative of early AD pathology.)",
  "timestamp": "2025-07-26T01:02:40.192996"
}